Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureRonald A. Asherson
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Phlegmasia alba dolens
1865
Effect of warfarin therapy on survival in small cell carcinoma (SCC) of the lung
10.1001/jama.1981.03310330021017 · 1981
Fibrin gel associated with line 1 and line 10 solid tumour growth, angiogenesis and fibroplasia in guinea pigs: role of cellular immunity, myofibroblasts, microvascular damage and infarction in line 1 tumour regression
1979
Abnormalities of blood coagulation in patients with cancer
10.1002/1097-0142(19830115)51:2<301::aid-cncr2820510223>3.0.co;2-7 · 1983
Cancer procoagulant: a novel vitamin K-dependent activity?
1981
‘Primary’, ‘secondary’, ‘catastrophic’ and other variants of the antiphospholipid syndrome
1996
Trousseau's syndrome with non-bacterial thrombotic endocarditis: pathogenic role of antiphospholipid syndrome
10.1016/s0002-9343(99)80355-6 · 1995
Antibodies directed against lipid membrane components in sera of patients with malignant tumours
1991
Increase of auto anti-phosphatidylinositol antibodies in plasma of female rats during the appearance of DMBA-induced malignant mammary tumours
10.1016/0304-3835(91)90057-o · 1991
Lymphoma associated bone marrow necrosis with raised anticardiolipin antibody
10.1136/jcp.51.5.407 · 1998
Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases
10.1002/ajh.2830190308 · 1985
Antiphospholipid antibodies, anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorder. Prevalence and clinical significance
10.7326/0003-4819-112-9-682 · 1990
Lupus anticoagulant: a clinical study of 100 cases
10.1111/j.1365-2257.1988.tb01152.x · 1988
For the members of the Registry. The Italian Registry of Antiphospholipid antibodies
1997
A prospective epidemiological study of the occurrence of antiphospholipid antibody; the Montpelier Antiphospholipid (MAP) Study
1994
Recurrent thrombosis and anticardiolipin antibodies associated with adenocarcinoma of the lung
10.1136/pgmj.66.774.316 · 1990
Lung cancer, immune thrombocytopenia and the lupus inhibitor
10.1136/pgmj.63.743.793 · 1987
Pulmonary embolism and lupus anticoagulant in a woman with renal cell carcinoma
10.1016/s0022-5347(17)32616-2 · 1994
A lupus antibody syndrome associated with hypernephroma
10.1002/art.1780221214 · 1979
A clinical study of the lupus anticoagulant
10.1182/blood.v48.4.499.499 · 1976
Axillary subclavian vein thrombosis following combination chemotherapy and radiation therapy in lymphoma
10.1016/0360-3016(86)90356-1 · 1986
A study of changes of coagulation inhibitors and fibrinolysis inhibitors in patients with liver cirrhosis and hepatoma
10.3346/jkms.1991.6.1.1 · 1991
Antiphospholipid antibody syndrome associated with ovarian cancer. A new paraneoplastic syndrome
1994
Right ventricular thrombus after pacemaker implantation in a patient with secondary antiphospholipid syndrome
1998
Recurrent stroke associated with thymoma and anticardilipin antibodies
10.1001/archneur.1987.00520180090026 · 1987
Cerebral infarction in a girl who developed anticardiolipin syndrome after acute lymphoblastic leukaemia
10.3109/08880019209016611 · 1992
Antiphospholipid syndrome during acute monocytic leukaemia
10.1111/j.1600-0609.1994.tb00183.x · 1994
Anticardiolipin antibodies in acute myeloid leukaemia: prevalence and clinical significance
10.1002/(sici)1096-8652(199802)57:2<139::aid-ajh8>3.0.co;2-x · 1998
Antiphospholipid antibodies: prevalence, clinical significance and correlation with cytokine levels in acute myeloid leukaemia and non-Hodgkin's lymphoma
10.1055/s-0038-1649628 · 1993
Chronic myelomonocytic leukaemia in a patient with antiphospholipid syndrome: first case report
10.1016/s0145-2126(97)00064-7 · 1997
Lupus-type coagulation inhibitor in hairy cell leukaemia and resolution with splenectomy
10.1111/j.1365-2141.1987.tb06149.x · 1987
Chorea in the antiphospholipid syndrome, clinical, radiologic and immunologic characteristics of 50 patients from our clinics and the recent literature
10.1097/00005792-199705000-00006 · 1997
Chorea, eosinophilia and lupus anticoagulant associated with acute lymphoblastic leukaemia
10.1016/0887-8994(92)90011-m · 1992
Antiphospholipid antibodies during chronic myelomonocytic leukaemia
10.1002/(sici)1096-8652(200001)63:1<60::aid-ajh15>3.0.co;2-3 · 2000
Systemic lupus erythematosus and lymphoma
10.1016/s0140-6736(78)92645-4 · 1978
Lymphocytic lymphoma and systemic lupus erythematosus. Their co-existence with antibody to the 8m antigen
1982
Non-Hodgkin's lymphoma in systemic lupus erythematosus. Report of four cases with ultrastructural studies in two
1981
Malignant lymphoma and acute SLE
10.1136/bmj.3.5821.291-a · 1972
Systemic lupus erythematosus and concomitant lymphoma. A case report
10.1080/22953337.1987.11719263 · 1987
Neoplasms of the immune system in rheumatoid arthritis
10.1016/0002-9343(85)90241-4 · 1985
Antiphospholipid syndrome associated with immunotherapy in patients with melanoma
10.1002/1097-0142(19940315)73:6<1621::aid-cncr2820730613>3.0.co;2-e · doi-reference
Induction of hypothyroidism by interferon alpha IIB (letter)
10.1016/s0140-6736(89)90157-8 · doi-reference
Graft-versus-host disease
10.1056/nejm199103073241005 · doi-reference
Waldenström's macroglobulinaemia in a patient with a chronic biologic false-positive test for syphillis
10.1016/0002-9343(74)90626-3 · doi-reference
Lupus anticoagulant associated syndrome in benign and malignant systemic disease—analysis of ten observations
10.1007/bf01737004 · doi-reference
A monoclonal IgM with antibody-like specificity for phospholipid in a patient with lymphoma
10.1182/blood.v43.4.493.493 · doi-reference
A new theory of interference with the clotting mechanism: the complexing of euglobin with factor V, factor VII abdomen prothrombin
10.7326/0003-4819-49-2-371 · doi-reference
Antiphospholipid antibody syndrome associated with peripheral T-cell lymphoma
10.1002/(sici)1096-8652(199707)55:3<167::aid-ajh12>3.0.co;2-a · doi-reference
Lupus anticoagulant associated with primary malignant lymphoplasmacytic lymphoma of the spleen: a report of four patients
10.1002/ajh.2830380404 · doi-reference
Cutaneous necrosis associated with the antiphospholipid syndrome and mycosis fungoides
10.1111/j.1365-2133.1994.tb06890.x · doi-reference
Antiphospholipid antibodies and Sezary syndrome (letter)
10.1002/ajh.2830490431 · doi-reference
Study of three patients with monoclonal gammopathies and ‘lupus-like’ anticoagulants
10.1111/j.1365-2141.1989.tb00256.x · doi-reference
Circulating anticoagulant, autoimmune hemolytic anaemia and malignant lymphoma
10.1097/00000441-197707000-00011 · doi-reference
Collaborative United Kingdom–Australian study of cancer in patients treated with immune suppressive drugs
10.1136/bmj.2.6203.1461 · doi-reference
Mixed connective tissue disease. Sjogren's syndrome and abdominal pseudolymphoma
10.1093/rheumatology/24.1.70 · doi-reference
Sjogren's syndrome and fibrosing alveolitis complicated by pulmonary lymphoma
10.1136/ard.46.9.701 · doi-reference